Tinactin

Product NDC
11523-0139
11-digit product format
115230139
Labeler code
11523
Product ID
11523-0139_4526df19-7a71-0f19-e063-6394a90a3954
Type
HUMAN OTC DRUG
Nonproprietary name
Tolnaftate
Dosage form
AEROSOL, POWDER
Route
TOPICAL
Labeler
Bayer HealthCare LLC.
Application
M005
Marketing category
OTC MONOGRAPH DRUG
Marketing start
2023-11-29
Substance
TOLNAFTATE
Active strength
10 mg/g
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Tinactin
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TOLNAFTATE10 mg/g

Harmonized Identifiers#

Field, Values table
FieldValues
Unii06KB629TKV
Rxcui705934, 705936

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11523-0139-1Tinactin133 g in 1 CANAEROSOL, POWDER1333

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11523-0139TINACTIN (TOLNAFTATE) AEROSOL, POWDER [BAYER HEALTHCARE LLC.]2Current NDC, 1 package rows20240524_0beda157-efd2-5245-e063-6394a90a6911.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
705936Tinactin 1 % Powder SprayPSN0beda157-efd2-5245-e063-6394a90a69113
705934tolnaftate 1 % Powder SprayPSN0beda157-efd2-5245-e063-6394a90a69113
705936tolnaftate 0.01 MG/MG Powder Spray [Tinactin]SBD0beda157-efd2-5245-e063-6394a90a69113
705934tolnaftate 0.01 MG/MG Powder SpraySCD0beda157-efd2-5245-e063-6394a90a69113
705936Tinactin 0.01 MG/MG Powder SpraySY0beda157-efd2-5245-e063-6394a90a69113
705936Tinactin 1 % Powder SpraySY0beda157-efd2-5245-e063-6394a90a69113
705934tolnaftate 1 % Powder SpraySY0beda157-efd2-5245-e063-6394a90a69113

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
11523-0139-111523013901133 g in 1 CAN (11523-0139-1) 133 g2023-11-29NoNoCurrent